ARCHIVES

Revlimid Plus Steroid Effective In Clinical Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

Study Validates “PEM” Scans As Biopsy Guidance Method

April 29, 2011

Phase II Study Shows Positive Results in Reducing Dry Mouth

October 25, 2013

In Brief: NCI Awards $1.2 Million To Mt. Sinai To Establish Specialized Cancer Center

July 26, 1974

Cancer Center Planning Grants Recompetition Approved By Advisors

June 10, 1994

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

In Brief: William Longmire Replaces Fisher On Cancer Panel; Talbot Urges Organizations To Avoid Polarization

July 9, 1982